During the past decade, II Medizinische Klinik - Klinikum Fuerth conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "II Medizinische Klinik - Klinikum Fuerth" are "Breast Cancer" (1 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "II Medizinische Klinik - Klinikum Fuerth" in a lesser frequency.

Most popular intervention types in "II Medizinische Klinik - Klinikum Fuerth" are "Biological" (2 trials), "Drug" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "allogeneic bone marrow transplantation" (1 trials), "busulfan" (1 trials), "cytarabine" (1 trials) and "darbepoetin alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "II Medizinische Klinik - Klinikum Fuerth" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "II Medizinische Klinik - Klinikum Fuerth". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in II Medizinische Klinik - Klinikum Fuerth, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in II Medizinische Klinik - Klinikum Fuerth, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".